INDIANAPOLIS — An Indianapolis strip club shut down abruptly this week following a police raid last week.
The raid by law enforcement led to charges for many of the workers of the club.
Club Onyx, which is part of a chain that includes locations around the country, is located on the city’s south side, announced the closure on their Instagram account.
As seen above, the post does no mention reasons for closing, but court documents show charges to multiple workers at the club. Charges range from involving illegal firearms, drugs and prostitution.
Two separate dancers allegedly engaged in public nudity and offered sex in exchange for money with undercover officers during visits to the bar in January and February.
Court documents also allege a bartender at the club was selling bottles of alcohol and drugs after hours.
Club Onyx Indianapolis was in the news for crime in the past.
In March 2022, two men were shot in the club.
IMPD police records show nearly five dozen calls to the 4444 S. Harding Street in 2022. That is the club's listed address.
WRTV has reached out to the club for a statement.
WRTV is also awaiting comment from the Alcohol & Tobacco Commission. The club was expected to go before the ATC for a license renewal hearing next week.
-
Gun rights, sports bans, tariffs — key Supreme Court rulings on the horizon
From tariffs to gun rights to sports bans, the U.S. Supreme Court’s decisions this term could reshape interpretations of the Constitution on personal rights and presidential power.
Zedd returns to headline 2026 Indy 500 Snake Pit
Electronic superstar Zedd is coming back to Indianapolis Motor Speedway, set to headline the 2026 Indy 500 Coors Light Snake Pit.
Bill that could bring Chicago Bears to Indiana advances in House committee
The Chicago Bears moved closer to relocating to Indiana Thursday as a House committee unanimously passed legislation creating the framework to finance a new NFL stadium in Hammond.
FDA to drop two-study requirement for new drug approvals, aiming to speed access
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs.